Syz Cephalandra NDC 85816-6014

NDC codes

FDA NDC Directory

Product NDC (as listed)85816-6014Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85816-6014Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85816-6014-1	85816601401	30 mL in 1 BOTTLE, GLASS (85816-6014-1)Marketed from Jan 1, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Syz Cephalandra
Generic name (nonproprietary): acid phos, cephalandra ind, gynmema syl, momordica charantia, syz jambol
Active ingredients: Momordica charantia fruit — 1 [hp_X]/mLCoccinia grandis whole — 1 [hp_X]/mLPhosphoric acid — 7 [hp_X]/mLGymnema sylvestre root — 1 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: BM Private Limited
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 1, 2015
Listing expires: Dec 31, 2026
Identifiers: Product ID 85816-6014_3b3a3776-96c1-f876-e063-6394a90aaec8SPL ID 3b3a3776-96c1-f876-e063-6394a90aaec8SPL set ID 3b3a3776-96c0-f876-e063-6394a90aaec8UNII UA63Y8U89U, S4R7X48WED, E4GA8884NN, C4PVO0UUEQ

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485816601401 followed by a unit qualifier and the quantity

Package 85816-6014-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 31, 2025.

Indications (excerpt from the label)

Help support to relieve the symptoms of diabetes mellitus, for detail page please read the enclosed package (product information leaflet).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)